These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21864238)

  • 1. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
    Lima JC; Rodriguez L
    Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
    Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
    Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
    Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
    Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
    Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
    J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
    Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
    Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
    Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
    Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of gold(I) phosphine complexes containing the 2-BrC
    Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
    Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Gold derivatives as anti-cancer agents.
    Raurell LR
    Anticancer Agents Med Chem; 2011 Dec; 11(10):920. PubMed ID: 22023049
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!
    Ali M; Dondaine L; Adolle A; Sampaio C; Chotard F; Richard P; Denat F; Bettaieb A; Le Gendre P; Laurens V; Goze C; Paul C; Bodio E
    J Med Chem; 2015 Jun; 58(11):4521-8. PubMed ID: 25973667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
    Liu JJ; Galettis P; Farr A; Maharaj L; Samarasinha H; McGechan AC; Baguley BC; Bowen RJ; Berners-Price SJ; McKeage MJ
    J Inorg Biochem; 2008 Feb; 102(2):303-10. PubMed ID: 18029019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the biological evaluation of gold anticancer agents.
    Fricker SP
    Anticancer Agents Med Chem; 2011 Dec; 11(10):940-52. PubMed ID: 21864236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and Selective Cytotoxic and Anti-inflammatory Gold(III) Compounds Containing Cyclometalated Phosphine Sulfide Ligands.
    Reddy TS; Pooja D; Privér SH; Luwor RB; Mirzadeh N; Ramesan S; Ramakrishna S; Karri S; Kuncha M; Bhargava SK
    Chemistry; 2019 Nov; 25(62):14089-14100. PubMed ID: 31414501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold(III) complexes in medicinal chemistry.
    Maia PI; Deflon VM; Abram U
    Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
    Casini A; Messori L
    Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
    García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
    Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and redox stability of [Au(III)(X^N^X)PR
    Sánchez Delgado GY; Paschoal D; de Oliveira MAL; Dos Santos HF
    J Inorg Biochem; 2019 Nov; 200():110804. PubMed ID: 31472435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
    Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
    Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.